Topical Cosmetic Products for Hand and Foot Syndrome

Launched by DERMOPHISIOLOGIQUE S.R.L · Sep 4, 2024

Keywords

ClinConnect Summary

Cancer patients undergoing active oncological treatment (chemotherapy, biological therapies, radiotherapy) experience multiple side effects, including skin toxicity, which negatively affects their quality of life, increasing the risk of interrupting cancer therapy. Symptomatic therapy is often neglected and prescribed late in the course of the disease. Many patients undergoing anti-cancer therapies experience adverse skin reactions such as dry skin, rashes, redness, and itching. Dry skin, erythema, and nail lesions are particularly common for those undergoing chemotherapy and targeted treat...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Cancer diagnosis undergoing oncological therapy with chemotherapeutic agents, targeted therapy, immunotherapy hormonal treatments
• • Patients with grade 1 of Hand-foot syndrome (HFS) Male and female patients 18 age or more
• • Conditions favoring the correct execution of the proposed program
• • Signature of informed consent, privacy and the form for the use of the data
• Exclusion Criteria:
• • Pregnancy or breastfeeding in progress
• • Other skin toxixities different from HFS
• • Patients with HFS adverse skin symptoms higher than grade 1
• • Psychic or other disorderes
• • Patients with preexisting skin disorders thet could interfere with thw study results (like dermatitis, prosriais)
• • Known hypersensitivity or allergy to one of the components of the products